DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Beyer-Westendorf J, Schellong SM, Gerlach H. , et al; SURPRISE investigators.
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.

Lancet Haematol 2017;
4 (03) e105-e113

Download Bibliographical Data

Access: